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The aim of this review is to provide a comprehensive update on the biology, epidemiology, clinical features,
diagnosis, treatment, and prevention of canine cardio-pulmonary angiostrongylosis. This cardiopulmonary disease is
caused by infection by the metastrongyloid nematode Angiostrongylus vasorum. The parasite has an indirect life cycle
that involves at least two different hosts, gastropod molluscs (intermediate host) and canids (definitive host). A. vasorum
represents a common and serious problem for dogs in areas of endemicity, and because of the expansion of
its geographical boundaries to many areas where it was absent or uncommon; its global burden is escalating.
A. vasorum infection in dogs can result in serious disorders with potentially fatal consequences. Diagnosis in
the live patient depends on faecal analysis, PCR or blood testing for parasite antigens or anti-parasite antibodies.
Identification of parasites in fluids and tissues is rarely possible except post mortem, while diagnostic imaging
and clinical examinations do not lead to a definitive diagnosis. Treatment normally requires the administration
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As a disease with a substantial animal health impact, ca-
nine angiostrongylosis remains a high priority for clini-
cians and researchers. Infected dogs usually exhibit signs
of respiratory and/or cardiovascular disease, and occasion-
ally coagulopathies and neurological signs, with fatal con-
sequences in severe cases [1,2]. This disease is caused by
the metastrongyloid nematode Angiostrongylus vasorumtd. This is an Open Access article distributed under the terms of the Creative
mons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
al work is properly credited. The Creative Commons Public Domain
ublicdomain/zero/1.0/) applies to the data made available in this article,
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dae). Even though A. vasorum was discovered over a cen-
tury ago in France [3] knowledge of its epidemiology and
clinical importance has grown in the last 20 years. In this
time, infection has dramatically increased in signifi-
cance and apparent incidence, and the parasite has ex-
panded from established “hotspots” into previously
uninfected areas. Popular theories include climatic change,
increased urbanisation of the red fox (Vulpes vulpes)
which acts as a reservoir host [4,5] and increased move-
ment of domestic dogs both within and between countries
[6]. However, the spread of the parasite is likely due to a
combination of these and possibly other factors, and
this makes infection with A. vasorum unpredictable.
Extremely valuable clinical observations have been ob-
tained in previous studies [7-11], including studies
examining moderate numbers of animals, e.g. 160 cases
[1] and 54 cases [12], which document trends in the sig-
nalment of presenting animals. However, more studies
with larger sample sizes in a range of settings are needed
in order to draw robust conclusions. The use of signal-
ment trends is valuable to veterinary practitioners, as it
allows improved education of dog owners and perhaps
facilitates faster diagnosis. Useful information includes
identification of at-risk breeds, or breed groups, as well
as some knowledge regarding the degree of influence
that the sex or age of an animal has upon likelihood of
infection. Likewise, knowledge of the way in which A.
vasorum affects physical parameters, haematological and
biochemical parameters assists practitioners in compiling
a list of differential diagnoses. When a diagnosis of A.
vasorum has been established it is useful for practitioners
to have additional information regarding the most effect-
ive treatment strategies.
Over the last few decades A. vasorum has not escaped
the interest of veterinary clinicians and parasitologists.
This is reflected in the variety and growing number of
scientific publications, which continue to advance the
knowledge on this parasite and the disease it causes.
Hence, we here review the seminal literature and sum-
marise the latest advances in the epidemiology, clinical,
and laboratory diagnostics of A. vasorum infection, and
discuss current treatment and prevention strategies.
Additionally, the historical perspective, biology, morpho-
logical characteristics and host specificity are discussed.
2. Historical perspective
The name A. vasorum was derived from the Greek words
“angion” meaning bottle, “strongylos” meaning round, and
“vasorum” meaning blood vessels. The pseudonym
“French Heartworm”, by which A. vasorum is commonly
known, was given based on the first locality from which
the parasite was recognized. When studying historical
accounts relating to the distribution of A. vasorum inToulouse, France in the 1800s to various countries
throughout Europe, Africa and the Americas to date, the
nematode appears to have spread at an alarming rate and
to a wide geographical expanse. Thus, from its initial recog-
nition in France, A. vasorum has been described in border-
ing countries within Northern Europe, whereby infection
appeared to establish within well-defined endemic foci.
There were also reports of A. vasorum infection within
canid populations outside of Europe, more specifically in
South America, Newfoundland in North America, and
Uganda [1,13]. For many years, very few cases of infection
were documented outside of these “hotspots”. More re-
cent studies have begun to highlight an apparent change
in the range of A. vasorum, reporting instances of infec-
tion from new localities a considerable distance from the
previously recognised foci [1,14,15].
3. Biology
3.1. Life-cycle of A. vasorum
The dioecious adult A. vasorum lives in the pulmonary
arteries and heart of the definitive hosts, i.e. dogs and
other canids, and produces eggs that hatch to first-stage
larvae (L1). These penetrate the alveoli, migrate up to
the oropharynx, after which they are swallowed and then
eliminated in the faeces. A definitive host can shed as
many as 280 000 larvae per gram of faeces [16]. These
L1 must infect a gastropod mollusc intermediate host
(slug or snail), for the development of the infective
third-stage larvae (L3), which occurs within 10-16 days
under optimum conditions [1,14,17]. Until now virtually
all investigated snails and slugs have proven to be able
to function as intermediate host to this parasite. Frogs
act as paratenic hosts, following the ingestion of infected
snails or slugs, and can also act as intermediate hosts
[18]. L3 of A. vasorum are able to infect the dog (Canis
familiaris) either directly, through ingestion of L3 present
in the environment, or indirectly, through ingestion of
an intermediate gastropod or paratenic (transport) host.
Then, L3 penetrate the gut wall and migrate to the ab-
dominal lymph nodes, where they moult to fourth-stage
larvae (L4); then enter the portal circulation, migrate
through the liver parenchyma and eventually reach the
right ventricle and pulmonary arteries, where they ma-
ture to adults. The time from which a definitive host is
infected to when larvae can be recovered from faeces,
otherwise known as the pre-patent period, is reported
to be 38–57 days; however, it can range widely from 28
to 108 days [19].
To date, no work has been done to determine whether
infection status affects longevity of molluscs experimen-
tally infected with A. vasorum. The survival of A. vasorum
larvae was found to be greater at lower temperatures,
with larvae remaining active until day 15 and alive until
day 24 at 5°C, while high temperatures can induce higher
Figure 2 SEM photograph of adult Angiostrongylus vasorum.
(A) Caudal region, (B) anterior region, (C) a higher magnification of
the anterior end showing the oral orifice. Scale bars; A &
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vasorum has been detected in dogs in Denmark [10]. A
study carried out by Morgan et al., [4] approximated
an eco-climatic index to predict the success of A. vasorum
establishment and growth in different climatic locations.
The index correlated a high eco-climatic index with areas
known to have high A. vasorum infection, thus highlight-
ing a potential use to anticipate infection in currently
non-endemic areas.
3.2. Morphological characteristics
The basic morphological appearance of A. vasorum is
like that of most nematodes, taking a cylindrical form
that tapers at each end. Members of the superfamily
Metastrongyloidea, to which A. vasorum belongs, are all
known to feature a small buccal capsule, rather than just
a simple oral aperture. Distinguishing features that allow
specific identification of A. vasorum can be split into
gross and microscopic categories and characterized by
sex and larval stage. Males are 14-18 mm in length, with
visible bursa, spicules and bursal rays, their ventral rays
are fused for the majority of their body and the dorsal
ray is short with short terminal branches. Females are
slightly larger, 18-25 mm in length, and have a gross
appearance similar to the “barber’s pole” appearance of
Haemonchus sp. The white ovaries of female A. vasorum
are wrapped in a coil around the intestine with the vulva
located in the posterior region of the body (Figures 1
and 2). The undifferentiated eggs that hatch from the
oviparous female develop into L1 larvae (Figure 3) that
are 280 to 330 μm in length, have an anterior cephalic
button, a dorsal spine and a sinus wave curve in their
tail [17,21]. Knowledge of L1 morphology is essential for
diagnosis using Baermann’s technique.Figure 1 Mimicking of adult Angiostrongylus vasorum in situ
using reconstructive filming. Note the characteristic barber’s pole
appearance of female worms in a still image taken from a filmed
sequence of adult live worms, which were collected from naturally
infected dogs and placed in a pig’s heart through which fluid
was pumped.
B = 1 mm; C = 10 μm.3.3. Host-specificity
It is now recognised that A. vasorum infection is com-
monly seen in wild canids, such as red foxes [22], which
act as reservoir hosts, and can also infect the wolf
(Canis lupus), coyote (Canis latrans), and jackal (Canis
aureus), as well as other wild canid species [23-25]. A
correlation between the prevalence of A. vasorum infec-
tion in foxes and in dogs has been suggested. This con-
nection has led to studies exploring other potential
reservoirs of infection that may threaten the dog
population. New potential definitive hosts, such as the
Eurasian badger (Meles meles) were identified [26,27].
Also, natural A. vasorum infection has been reported
in captive red panda (Ailurus fulgens) in the United
Kingdom and Denmark [28,29] and in free living otters in
Denmark [30].
Figure 3 Angiostrongylus vasorum first-stage larva recovered
from faeces using the Baermann technique. Note the
characteristic kinked tail of the larva with a sinusoidal curve and a
spine and distinct notch on the dorsal surface.
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A. vasorum is recognised as having a worldwide distribu-
tion. But, when focussing on the enzootic prevalence of
A. vasorum globally there are limited data from which to
draw conclusions. No national or international surveil-
lance mechanisms are in place to determine the preva-
lence and global distribution of A. vasorum infection.
The geographic distribution of A. vasorum in the Americas
and Africa is less defined than in Europe, thus preventing
the assumption of global “trends” in infection. Nonetheless,
canine angiostrongylosis is considered endemic in certain
areas of Europe, including regions of Denmark, Germany,
Hungary, Finland, France, Ireland, Italy, the Netherlands,
Poland, Slovakia, Spain, Sweden, Switzerland, Turkey and
the United Kingdom, in Canada (Newfoundland), in South
America (Brazil and Colombia), and in Uganda in Africa.
The country list is growing as the A. vasorum geographic
distribution continues to evolve in several countries of
Europe [31], and there is a growing risk of establishment
in the Americas [32]. Studies carried out within dog popu-
lations in the United Kingdom, Denmark, Germany and
Greece estimate the prevalence of A. vasorum to range
from 0.3-9.8%. Estimated prevalence varies widely be-
tween different canine populations (e.g. pet, hunting or
stray dogs), health status (e.g. clinically affected or
healthy), and methods used (e.g. variations on coprolo-
gical methods). This is in contrast to studies within fox
populations in Canada, Denmark, Hungary, Italy, and
Spain, which estimate prevalence of A. vasorum to be
often higher at 5-56% [1]. These data suggest that foxesare the most important reservoir of infection, but must
be interpreted with care, as figures exclude the recently
recognised shifts in prevalence both within and outside
of regions of endemic foci [6].
4.1. Pattern of spread
Information on the exact geographic range of A. vasorum
in dogs is lacking due to apparent expansion both around
known endemic foci and into previously free regions.
Attention should be drawn to the fact that the lack of
evidence of A. vasorum in a given region does not en-
sure its non-existence, and therefore, geographic loca-
tion should not be used as the sole criterion to suspect
or rule out diagnosis. Likewise, increasing awareness of
the parasite among clinicians and parasitologists has
driven surveillance and recognition of infection in an
expanding area, some of which might have been pre-
existing. However, this is unlikely to fully explain apparent
range expansion, given that such a highly pathogenic dis-
ease would not lie unrecognised for so long in countries
with a well-developed veterinary clinical sector. A caveat
worth mentioning here is that this disease may go un-
noticed unless clinicians are looking for it or test for it
since making a clinical diagnosis can be difficult because
of varying magnitudes of severity and a variable and some-
times vague presentation.
In Europe, A. vasorum is known to be spreading into pre-
viously un-infected areas in Denmark, Germany, Greece,
the Netherlands, Ireland, Italy, Sweden and the United
Kingdom [6,10,11,33–36]. In the British Isles, A. vasorum
infection was first reported in a Greyhound in Ireland in
1968 [37] and 7 years later a single infection was reported
in England in a Greyhound that had been imported from
Ireland [38]. Following this, the infection has rapidly
spread to establish regions of endemic foci in the South-
West, as well as the South-East of England and Wales.
Furthermore, subsequent studies have identified new
pockets of A. vasorum infection in both dog and fox
populations reaching the North of England [39], Scotland
[40] and Ireland [41]. This pattern of expansion appears
to be repeated at a range of scales, and in some cases
the disease is appearing in different countries, for ex-
ample, A. vasorum infection has been reported for the
first time in a native dog in Slovakia in 2013, [42], the
latest in a long series of new national records in Europe.
In North America, the situation is different to that seen in
South America and Europe. Until recently, Newfoundland
in Canada was regarded as the only A. vasorum endemic
location in North America [9]. However, an autochthon-
ous infection has been recently identified in the lungs of a
red fox from West Virginia, USA [15]. Two cases of nat-
ural A. vasorum infection had been previously reported in
domestic dogs in the USA; one at Michigan State University
in 1985, in a Greyhound imported from Ireland [43]
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based on the tentative identification of A. vasorum in
the faeces [44].
It is difficult to say why A. vasorum has spread in the
manner that it has, and why it is moving to different loca-
tions. Three of the more commonly proposed hypotheses
are climate change, urbanisation of red fox populations
and increased pet movements. Other equally plausible ex-
planations include the increasing awareness of A. vasorum
within the veterinary profession and continually improv-
ing, more readily available diagnostics. A recent report,
analysing the genetic sequence in nematodes recovered
from Europe and South America, questioned previous as-
sumptions about the worldwide spread of A. vasorum
from France. It is likely that A. vasorum in Europe and
South America occurred as a result of evolutionary diver-
gence along with canid radiation (Figure 4), rather than
recent historical spread [13,45].
4.2. Risk factors and at risk-populations
Published data in the United Kingdom suggest that some
purebred dogs are at higher risk than crossbreeds, and in
particular Cavalier King Charles Spaniels and Staffordshire
Bull Terriers [8] and beagles [9]. Reports of breed pre-
disposition might reflect popular breeds in the locations
assessed. However, data from Canada suggest a higher
prevalence in hunting dog breeds [9,32], and data from
The Netherlands, Germany, Denmark and Italy do not
report breed preferences [10,11,34]. The most likely age
for infection has been reported as around 10 months
[7,8]. There are no data to suggest that age, sex or body
condition influence A. vasorum infection in foxes [5].
4.3. Role of wildlife reservoirs
Besides the natural definitive host (domestic dog), A.
vasorum has been reported from a wide range of wild
canids in several geographic areas (reviewed in [1,14]). The
lack of genetic separation between A. vasorum obtainedFigure 4 Phylogenetic relationships among three species of Angiostron
sequences of COI and ITS-2 using the Kimura two-parameter model of nucleo
the internal nodes. Taxa are labeled with the species, strain designation, and cfrom dogs, foxes and coyotes supports the hypothesis that
transmission can occur between wild and domestic canids
[13]. Indeed, infection in dogs seems to occur due to geo-
graphic over-lap with wild canid hosts [14].
The most important and best-studied wildlife reservoir
for A. vasorum infection is the red fox (Vulpes vulpes).
A possible explanation for increased transmission of in-
fection between red fox and dog populations is an in-
creasing density of foxes. It can be assumed that an
increased density of foxes in an area populated with dogs
is likely to increase the number of fox-dog interactions,
and hence increase the opportunity for transmission of
infection. Direct wild canid-dog interaction is not neces-
sary for (and does not lead to) transmission of this para-
site from one to the other because transmission occurs
via ingestion of L3 (in gastropods or frogs, or possibly
free in the environment). An unrelated disease outbreak
could decrease the overall health of foxes, and hence in-
crease susceptibility to A. vasorum infection. This could
have been the case in the United Kingdom, where A.
vasorum infection appeared simultaneously with an out-
break of sarcoptic mange [14], although this outbreak
was also associated with a marked decrease in fox popu-
lation density, which should have reduced A. vasorum
infection pressure.
Studies in the United Kingdom have demonstrated a
prevalence of 23.2% A. vasorum infection in fox popula-
tions residing in a known endemic hotspot for dog infec-
tion, compared to a countrywide prevalence of 7.3% [5].
Interestingly, we identified one case of A. vasorum in
red fox in the Midlands of England (Figure 5), which
may explain the recently identified cases of canine infec-
tion in that locality [4,46]. This finding would corres-
pond with the situation in Canada, whereby A. vasorum
infection was first identified in red foxes in Newfound-
land in 1973, where the parasite is still endemic [47], be-
fore it emerged in domestic dogs in 1996 and then in
coyotes in 2003 [25,48–50]. A. vasorum was recentlygylus. Neighbor joining analysis was conducted on the concatenated
tide substitution. Bootstrap values based on 500 replications are given at
ountry of origin for each isolate.
Figure 5 Photograph showing Angiostrongylus vasorum in situ.
Adult male and female A. vasorum (arrow) in the heart of a red fox
from the East Midlands region, England.
Figure 6 Radiographic feature of Angiostrongylus vasorum.
Latero-lateral thoracic radiograph of an 18 month old English Setter,
before treatment for Angiostrongylus vasorum. Diagnosis was confirmed
by faecal analysis. Note the marked bronchial-alveolar pattern (arrows).
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of A. vasorum had been identified in a dog that had
never travelled [40].
While A. vasorum is commonly found in and known
to cause pathology in red foxes [5,52], only two cases
have been described in wolves, first in northwestern
Spain [23] and recently in Rome, Italy [24], again coin-
ciding with increasing records of A. vasorum in dogs
and foxes in the same geographic region, where infection
with the parasite is also expanding in dogs [31,36].
Eurasian badgers, Meles meles (Linnaeus, 1758) have
been identified as potential reservoirs for infection, how-
ever their role in transmission to dogs remains uncertain
[26]. Much remains to be understood about the dynam-
ics of infection in wild populations and factors under-
lying spill-over to dogs.
5. Disease clinical features
Infection with A. vasorum may be asymptomatic in
some cases or may result in a wide spectrum of clinical
signs, ranging from mild respiratory manifestations to
severe forms [1], which are characterized by coagulative,
respiratory or neurological disorders [53]. Respiratory
signs are the most common clinical manifestations, with
coagulation disorders being less common but more
likely to be fatal. Ocular signs, including intraocular lar-
val migration, while rare, have been reported [54].
5.1. Pulmonary
By far the most common clinical presentations in dogs
diagnosed with A. vasorum are pulmonary related. Themost significant of these are coughs (either productive
or unproductive), and dyspnoea, with or without tachyp-
noea. Related clinical signs that are less commonly reported
are intolerance to exercise and lethargy. It is expected that
a dog positive for infection with A. vasorum would show
some pulmonary changes upon lateral or ventrodorsal
radiography (Figure 6). General findings include increased
interstitial, peribronchial and alveolar patterns, pneumo-
thorax [16,55,56], subcutaneous emphysema and an ab-
normally wide cranial mediastinum. The most common
signs noted upon radiographic analysis are an alveolar in-
filtrate and bronchial thickening. Characteristic serpigin-
ous/circular areas of radiopacities have been detected in
asymptomatic dogs, which were attributed to fistulas de-
veloped during migration of larvae from the pulmonary
capillaries into the alveoli [57]. There is some evidence as
to the time following infection that clinicians should ex-
pect to see radiographic changes. It has been suggested
that five to seven weeks after infection a bronchial-
interstitial pattern can be observed, which will be most
obvious at nine weeks post infection, and decrease up
until approximately twenty one weeks when evidence
of fibrosis will be seen [7]. Correlation between time
and radiographic pattern can be followed in experi-
mentally infected dogs [58] using computer tomog-
raphy. It is evident that there are always fibrotic tissues
left, showing that after A.vasorum infection the lesions
cannot fully regress.
5.2. Coagulopathy
A less common but often more severe consequence of
infection is a varying degree of coagulopathy [14]. Des-
pite recent interest in this aspect of infection there is
actually very little evidence based knowledge of how or
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be wide ranging with some animals presenting with clin-
ical or clinico-pathological signs more suggestive of pri-
mary (e.g. Disseminated Intravascular Coagulation (DIC)
[59], immune-mediated thrombocytopenia [60,61]), sec-
ondary and tertiary coagulopathy (dysregulation of the
anticoagulation pathway [59,62]) or combinations of the
three. Abnormalities attributed directly to coagulopathies
include haematoma, anaemia, intracranial haemorrhage,
sub-conjunctival haemorrhage, melaena and increased
post traumatic bleeding tendencies.5.3. Cardiovascular
Cardiovascular abnormalities associated with infection
include; attenuated cardiac sounds, myocarditis, heart mur-
murs of grade II to VI, heart failure, periarteritis, pale
mucous membranes and haematoma (causing pulmon-
ary hypertension or right heart failure secondary to ob-
struction) [8,60]. Pulmonary hypertension occurs in
less than 5% dogs infected with A. vasorum in primary
practice but affects up to one third of infected dogs
presenting at referral practice, documented by echo-
cardiography [1]. Echocardiology of dogs positive for
A. vasorum has indicated dilation of the right ventricle
and atrium, a bulging interatrial septum, dilated vena
cava and hepatic veins, and a severe tricuspid incom-
petence [63,64]. Some abnormalities identified upon
cardiac radiography include right ventricular enlarge-
ment, truncated pulmonary arteries and an increase in
vertebral heart scale. Cardiac abnormalities are rela-
tively rare and therefore not that commonly diagnosed,
in some cases Doppler ultrasound is used as a supple-
mentary method [7,63].5.4. Nervous
Neurological clinical presentation of A. vasorum infection
is less frequent than cardio-vascular and pulmonary, but is
still of clinical importance. Most neurological signs arise
from bleeding in or around the central nervous system,
secondary to coagulopathies. Neurological deficits or ab-
normalities will reflect the area of CNS haemorrhage and
prompt clinicians to consider testing for A. vasorum in
young animals with acute onset central neurological signs
before embarking on expensive and potentially risky CNS
imaging whether they present with or without respiratory
signs. Neurological defects associated with A. vasorum in-
fection are difficult to diagnose using conventional radio-
graphs; instead MRI and CT imaging can be used. Studies
using these techniques have noted accumulation of fluid
on the spinal cord, intramedullary haemorrhage and intra-
parenchymal haemorrhage in infected dogs [60,61,65,66].
Although nervous signs may be due to the disseminated
spread of L1 no reported cases to date reflect neurologicalsigns secondary to ectopic parasite or hypoxia as has been
previously speculated [1,8,57,65,67].
6. Diagnosis of angiostrongylosis
6.1. Laboratory diagnosis
6.1.1. Pathological findings
Post mortem reports in dogs and foxes infected with A.
vasorum show evidence of a thickened right ventricle,
with pneumonia and breakdown in alveolar structure
[5,68]. Histopathological analysis typically reveals the pres-
ence of inflammatory cells, in particular neutrophils, and
granulomatous foci with multinucleated giant cells, a pat-
tern also seen in less usual definitive hosts such as the
wolf [24] and coyote [25]. These observations are attrib-
uted to the inflammatory response to eggs and migrating
larvae [1]. A number of studies have shown the presence
of immature and adult nematodes in ectopic locations, for
example in the eye [54,66,69], where they can provide a
highly suggestive ante mortem diagnosis.
6.1.2. General laboratory findings
Various haematological and biochemical abnormalities
have been noted in infected dogs, including increased
ß-globulin fraction, anaemia, eosinophilia, thrombocytopenia,
hypercalcaemia and low serum fructosamine. However,
these vary between cases, with no typical or pathogno-
monic profile evident [2,70,71]. While peripheral eo-
sinophilia is not a consistent finding in dogs with
angiostrongylosis, if present in an animal with appro-
priate clinical findings it should prompt investigation
for the parasite. Coagulation parameters are also in-
consistent, even in cases with clinical coagulopathies
[8,59]. Thromboelastography is a useful technique, both in
terms of giving additional information about the kind of
coagulopathy, and also in follow-up assessment.
6.1.3. Parasitological findings
The most common method for diagnosing A. vasorum
infection is the Baermann migration-sedimentation tech-
nique, in which larvae are recovered from faeces and
identified based on morphological features. Larvae have
a characteristic sinusoidal terminal appendage that is
quite unlike other parasitic and non-parasitic nematodes
commonly found in dog faeces [72]. However, the fact
that larvae cannot be found in the faeces during the pre-
patent period, and the limited sensitivity of the test on a
single faecal examination, are important limitations of
the test [73]. This has led to modifications attempting to
improve the diagnostic value of faecal larval analysis
[74]. Sensitivity can be improved by pooling faeces over
a three day period [1], but this and the fact that the
Baermann test can take up to 24 hours to yield results,
makes it onerous in clinical practice. Early examination
of the Baermann’s test leads to more rapid results but at
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faeces is a simple test to perform at the pet-side but with
a low sensitivity of up to 54-61% [6,75]. L1 may be de-
tected in faecal flotation preparations, but do not float
reliably in standard flotation solutions, and so are un-
likely to be found in routine screening tests for parasite
ova. FLOTAC, an improved flotation-based coprological
method for visualising parasite eggs, oocysts and larvae
in faecal samples, has been found to be more sensitive
than the Baermann method for detecting A. vasorum L1
when used with higher specific gravity solutions [76].
Bronchoalveolar lavage (BAL), in which fluid is injected
into and then recovered from the lungs and analysed for
the presence of larvae, can be useful to demonstrate in-
fection [77], but is difficult and not without risk, espe-
cially in dyspnoeic patients. It is worth mentioning,
however, that evidence for the utility of BAL in the diag-
nosis of angiostrongylosis [77] was based on experimental
findings and, hence might not accurately reflect perform-
ance in clinical cases.6.2. Immuno-diagnosis
6.2.1. Antigen-based assays
Detection of circulating parasite antigen was identified
as a promising diagnostic approach [73], and an antigen
blood test is now commercially available in the form of
an in-hospital lateral flow device (AngioDetect®, Idexx
Laboratories, USA). The test can be performed on plasma
or serum with results obtained in 15 minutes. Antigen de-
tection by Enzyme-linked immunosorbent assay (ELISA)
has a high specificity (94%) and sensitivity (95%), much
higher than faecal examination [78]. As such, this is likely
to be increasingly relevant to clinical diagnosis in practice,
as well as monitoring of parasite distribution and spread
[79]. Baermann can still be a reliable method for diagnosis
of A. vasorum, if performed appropriately.
Antigen is reported to be detectable around five weeks
after experimental infection, hence during the pre-patent
period, and to persist until after elimination of the para-
site, while cross-reactions with other common canine par-
asites were not found [78]. Commercial antigen-detection
kits for Dirofilaria immitis, on the other hand, were tested
with sera from dogs infected with A. vasorum, and some
cross-reactions were detected [80]. Given the emergence
of A. vasorum in areas endemic for D. immitis [15], this is
of some concern. It is also worth mentioning that initi-
ation of adequate treatment has been shown to decrease
the level of detected circulatory antigens. No circulating
antigen was observed in dogs treated with imidacloprid/
moxidectin at 4 or 32 day post infection (dpi), while in
dogs treated at 88-92 dpi, circulatory antigens decreased
within 13-34 days [78]. Antigen detection could therefore
be useful as an indicator of response to treatment.6.2.2. Antibody-based assays
Detection of specific antibodies against A. vasorum also
hold potential for clinical diagnosis [81]. However, a
study using Western Blot and ELISA serology of 14 dogs
experimentally infected with A. vasorum, successfully
identified only five animals over a period of 0-56 dpi
[82]. Other attempts to identify antibodies, based on
crudely extracted parasite antigens, suffered from lack
of specificity [83]. Further work has been carried out to
identify specific proteins produced by both L1 and
adult nematodes, that are recognised by antibodies, in
order to improve the sensitivity of such tests [84,85]. A
novel antibody-detection ELISA, based on monoclonal
antibodies to A. vasorum, succeeded in achieving high
sensitivity and specificity [80], and has been applied
alongside antigen-detection in serological surveys [46,79].
In theory, persistence of antibodies in dogs historically in-
fected could lead to false positives when using antibody
detection as a clinical diagnostic tool, especially in areas
with high background levels of exposure. Hence, antibody
testing alone is of limited value except as a means of
screening for exposure in presumably non-endemic re-
gions. The options for combining antigen and antibody
detection ELISA in clinical and epidemiological settings
are discussed in Schnyder et al. [46]. There may also be
some potential for combining an antibody detection
ELISA with the Baermann technique to increase the lat-
ter’s sensitivity but retaining the early detection benefits of
the former.
6.3. Molecular techniques
Polymerase chain reaction (PCR) has been used to suc-
cessfully recognise unique nucleic acid sequences of A.
vasorum [40]. Real-time PCR was developed for A.
vasorum in definitive and intermediate hosts, and shown
to be capable of detecting DNA circulating in canine
blood [81,85]. Although highly specific and requiring a
blood sample rather than faeces, real-time blood PCR
offered no great advantage over the Baermann test in
terms of sensitivity in naturally infected dogs [85]. PCR
has also been used to detect A. vasorum in the faeces of
dogs [83] and foxes [86]. However, PCR inhibitors in fae-
ces can limit sensitivity and there is no obvious advan-
tage over the Baermann test unless faeces are to be
stored for long periods prior to examination, such that
L1 die and are unable to migrate in the Baermann appar-
atus. PCR can also be useful in cases where faecal Baer-
mann is not suggestive of a diagnosis of L1 of A. vasorum
because they are morphologically altered or less motile
than usual. However, the effect of treatment (e.g. fenben-
dazole) on the size or motility of the larvae prior to fae-
cal screening remains unknown or poorly understood.
PCR may be also useful in instances where a clinician
is faced with a case that clinically resembles A. vasorum
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pathological evidence of bleeding diathesis) but faecal
analysis is not supportive.
6.4. Problems in diagnosing angiostrongylosis
Clinicians are faced with many diagnostic challenges when
it comes to definitively identifying A. vasorum infection in
a patient. In this regard several points are worth mention-
ing. Firstly, due to the recent erratic and somewhat unex-
plained spread of infection, from the classified ‘hotspots’
to previously uninfected areas, it is no longer possible to
reliably determine whether an animal is at a high or low
risk of infection according to its location. Secondly, it is
possible that a clinician may overlook clinical signs sug-
gestive of A. vasorum infection, and treat for a condition
with a similar presentation such as kennel cough, because
of a belief that A. vasorum is not present in the area.
Thirdly, it is widely accepted that tests such as Baermann
faecal examination do not always recognise the presence
of A. vasorum in an animal, especially in pre-patent infec-
tion or as a result of low larval loads, intermittent larval
shedding, poor sample quality or operator error. Finally,
the low performance of faecal tests in terms of sensitivity
and immediacy has led many clinicians to treat presump-
tively for angiostrongylosis in suspicious cases, rather than
pursue a definitive parasitological diagnosis. This has the
disadvantage of removing an important source of evidence
to the clinician on local level of risk, as well as monitoring
of treatment success. Blind treatment, without attempts
to make a diagnosis, in cases of high suspicion should
be discouraged for this reason and because the required
duration of treatment is dependent on the animal not
continuing to shed L1. Wider availability of pet-side
antigen-detection tests is likely to provide important
clinical and epidemiological information in the future,
on which decisions on treatment and prevention re-
gimes can be based.
7. Treatment
A. vasorum is susceptible to a variety of anthelmintics.
Historically levamisole and ivermectin were routinely
used but this has not been the case in the past decade.
This is in part due the risk of anaphylaxis with levami-
sole use [87], the risk of toxicosis with ivermectin use in
any breed with an MDR 1 mutation (e.g., collie breeds),
and, most importantly, safer and licensed products be-
coming available. Fenbendazole remains a popular treat-
ment of choice and is efficacious at 25-50 mg/kg for 5-21
days [1,12,88], but in many territories is not licensed as a
treatment for A. vasorum. The reasoning behind fenben-
dazole use is that it produces a “slow kill” and therefore
reduces the risk of anaphylaxis but there remains no peer
reviewed data to support this theory. There are currently
only two widely licensed parasite treatments that includeA. vasorum among their label claims. One is a moxidectin/
imidacloprid spot-on solution (Advocate®, Bayer Animal
Health) and the other a milbemycin oxime tablet, in com-
bination with praziquantel (Milbemax®, Novartis Animal
Health). Moxidectin has been shown to be effective in re-
moving adult A. vasorum and immature stages (L4 and
L5) and milbemycin in reducing levels of adult and imma-
ture adult (L5) infection [12,89]. Moxidectin requires a
single monthly spot-on application to eliminate infection.
Milbemycin requires weekly oral administration for 4 weeks
to treat clinical A. vasorum infection. Both are highly effi-
cacious treatments. The study comparing the efficacy of
moxidectin/imidacloprid to fenbendazole [12] as a treat-
ment option actively excluded severe cases of angiostron-
gylosis and therefore little is known about this drug’s
performance in severe cases. Milbemycin was also recently
shown to have 98.8% preventative efficacy against devel-
opment of adult A. vasorum infection in a combination
product with spinosad (Trifexis®, Elanco Animal Health)
but at the time of writing this combination is not yet li-
censed for A. vasorum treatment and prophylaxis [90]. Li-
censed claims often differ between territories and change
with time, and readers are advised to check on the current
situation in their locality before making recommendations
on treatment. Supportive treatment is often indicated, de-
pending on the clinical presentation. Anti-inflammatory
doses of steroids have been used to moderate potential
anaphylaxis and/or treat significant respiratory signs [54].
Oxygen administration is also indicated in the respiratory
compromised patient. Patients with coagulopathies have
received lifesaving treatment with coagulation factors de-
livered in fresh frozen plasma or whole blood, although
cases with coagulopathies may recover also with treatment
of the parasite alone [63]. Where congestive heart failure
is present as a result of infection then treatment with di-
uretics, ACE inhibitors and phosphodiesterase inhibitors
(e.g., pimobendan or sildenafil) for pulmonary hyperten-
sion, are indicated.
8. Control and prevention
Eradication of A. vasorum is impractical in any given
area since significant reservoirs of infection will almost
certainly be present in the wild fox and intermediate
host populations. Measures should be considered to avoid
dogs consuming L3 (third stage larvae) either directly or
in gastropod molluscs. These include feeding dogs
indoors, cleaning outdoor bowls and toys frequently (or
making them less accessible to slugs/snails) to reduce the
risk of contamination with L3.
While molluscicides can be employed to reduce slug
and snail abundance, many of these are not pet safe and
to prevent access of pet dogs to molluscs completely is
unrealistic. Infected molluscs killed by pesticides in gar-
dens might be more available to dogs and actually increase
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ing desirable for control of parasites such as Toxocara
canis, is unlikely to make a significant impact on environ-
mental contamination with L1 as current data suggest that
domestic dogs are a much smaller reservoir of infection
when compared to foxes; nevertheless, treatment of dogs
and faecal removal might enhance local protection, for ex-
ample if environmental contamination is predominantly
from dogs in one locale, or in public areas highly fre-
quented by dogs. An interesting recent study has experi-
mentally explored the use of nematophagous fungi in the
environmental control of A. vasorum, by demonstrating
an efficacious destruction of L1 [91], but currently anthel-
mintic prophylactic treatment remains the mainstay of
disease prevention. Education is essential to raise public
awareness as canine angiostrongylosis continues to be
seen with increasing frequency in regions where it was not
traditionally thought to be endemic and it should be con-
sidered an emerging disease of which veterinarians should
be aware. Moxidectin and milbemycin oxime can be used
effectively for A. vasorum prophylaxis if used monthly
[89,90]. So far, no report has been published on resistance
of A. vasorum to chemotherapeutic compounds and large
intermediate host and wildlife reservoirs are expected to
buffer against resistance. However, long term excessive
treatment may potentially favour the development of an-
thelmintic resistance and as a result the need for monthly
prophylaxis should be based on risk factors such as
whether the patient is known to come into frequent
contact with slugs or snails or has had previous expos-
ure to the parasite. Prophylactic treatment should be
initiated in all dogs having suffered from A. vasorum in-
fection as it would imply that the area is endemic and
the dog is coming into contact with the intermediate
host. Alternatively, dogs may be regularly checked for
the presence of A. vasorum, something that is easier with
the availability of the new diagnostic tests described
above.
9. Conclusions
On any ranked list of cardiopulmonary nematode para-
sites of veterinary importance, A. vasorum would have
to lie towards the top. In recent years the threat of A.
vasorum to companion animal populations has become
increasingly apparent. This parasite has considerable
impact on dogs’ health and has shown both regional en-
demicity and geographic expansion. Going from its ori-
ginal discovery in France in the 1800s [3], to the recent
cutting-edge elucidation of the A. vasorum proteome
[92], mitochondrial genome [93] and transcriptome [94]
considerable insights into understanding of the contri-
bution of virulence determinants to the pathophysio-
logical aspects of canine angiostrongylosis have been
gained. However, important gaps remain in the availableliterature surrounding the epidemiology of infection. It
would be useful to establish why infection is so preva-
lent in hotspots around the world and the factors that
cause infection to spread. The role of red foxes and other
wild canids in the transmission cycles of A. vasorum is not
adequately understood. Also, the prevalence and geo-
graphic distribution of A. vasorum among wild canids, as
well as how A. vasorum was introduced to new localities
(e.g. the USA) warrant further epidemiological investiga-
tion. Attention should be drawn to the fact that the lack
of evidence of A. vasorum in a given region does not guar-
antee its nonexistence. Thus, location should not be used
as the sole criterion to suspect or rule out diagnosis.
While intense investigations in multiple directions have
been conducted to elucidate the mechanisms conducive
to the development of coagulopathies, no consensus has
yet emerged. Knowledge of this may help to reduce the
number of fatal cases observed. Better control of A.
vasorum will have implications for the health of domestic
dogs. Development of a safe and efficacious canine vaccine
for the prophylaxis of angiostrongylosis disease could,
if feasible, be a significant tool in future prevention
programmes.
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